GIMBHI’s daily mental health update — 8/27/26

🏛️ HHS awards $96.7M in SAMHSA grants for behavioral health services nationwide (Cailey Gleeson, Fierce Healthcare) — 08/19/26 TL;DR: HHS distributed $96.7M in SAMHSA grants, with $63.4M for homelessness transition support (PATH), $16.8M for youth suicide prevention, $7.1M for early psychosis intervention, and more.

🏛️ FDA selects SonderMind, Limbic, Cadence, and Dexcom for TEMPO digital health pilot (FDA Digital Health Center of Excellence) — 08/21/26 TL;DR: FDA’s TEMPO pilot will exercise enforcement discretion for four digital health devices — including SonderMind and Limbic’s behavioral health apps — used within CMS’s ACCESS chronic care model, in exchange for real-world outcomes data.

🏙️ Cityblock acquires Homeward Health and raises $116M Series E led by General Catalyst (Toyin Ajayi, Cityblock Health) — 2026
TL;DR: Cityblock is buying Homeward Health in an all-stock deal alongside a $116M Series E to combine urban Medicaid/dual-eligible expertise with rural Medicare Advantage, serving ~200,000 members at $2.2B annualized revenue.

💊 Scoop: Johnson & Johnson set to lead Delix Therapeutics’ $85M Series C (Josh Hardman, Psychedelic Alpha) — 08/18/26 TL;DR: J&J signed a term sheet to lead neuroplastogen developer Delix’s $85M Series C at a $190M pre-money valuation, with rights of first negotiation on lead candidate DLX-001 post-Phase II depression data.